Peek and Treat Approach to Diagnosis, Treatment and Monitoring of AD


The objective of this project is to develop a nanotechnology platform that can simultaneously be used to diagnose and treat Alzheimer’s. The work will explore how to develop multifunctional nanocarriers that contain both an imaging agent and a therpeutic agent and also will improve the binding capabilities of the nanocarrier allowing regulation of the release of therapeutic molecules to amyloid lesions.

Funding to Date



Drug Discovery


Ananth Annapragada, Ph.D

Jason Eriksen, Ph.D.